J Korean Ophthalmol Soc > Volume 54(3); 2013 > Article
Journal of the Korean Ophthalmological Society 2013;54(3):396-400.
DOI: https://doi.org/10.3341/jkos.2013.54.3.396    Published online March 15, 2013.
The Effects of Intralesional Steroid Injection for Chalazion According to the Concentrations of Triamcinolone Acetonide.
Eun Joo Kim, Sung Yu, Byung Jin Jeong, Kyoo Won Lee, Hong Jae Mun
Cheil Eye Hospital, Daegu, Korea. drmhj92@hanmail.net
콩다래끼 병소 내 스테로이드 국소 주사 시 스테로이드 농도에 따른 치료 효과 비교
김은주⋅유 성⋅정병진⋅이규원⋅문홍재
Cheil Eye Hospital, Daegu, Korea
Abstract
PURPOSE
To compare the efficacy of an intralesional steroid injection in the treatment of chalazion according to triamcinolone acetonide (TA) concentrations. METHODS: A total of 108 patients with 120 chalazia received an intralesional injection of TA. Patients were divided into 3 groups according to the concentrations of TA: 5 mg/ml, 10 mg/ml, and 40 mg/ml. A regular follow-up was performed and the size of lesion and recurrence were evaluated. RESULTS: Success was defined as a minimum of 80% decrease in size with no recurrence. The success rate was 78.1% in the 5 mg/ml group, 76.2% in the 10 mg/ml group, and 78.4% in the 40 mg/ml group. These results were not statistically significant (p = 0.999, Fisher's exact test). Yellow deposits developed in 4 out of 37 lesions in the 40mg/ml group, and in 1 out of 42 lesions in the 10 mg/ml group. Skin depigmentation was observed in 1 case in the 5 mg/ml group. CONCLUSIONS: Intralesional TA injection is an effective treatment for chalazion. There is no significant difference in success rates according to the concentrations of TA. However, caution is advised in cases of high injection concentrations of TA to prevent yellow deposits.
Key Words: Chalazion;Intralesional injection;Triamcinolone acetonide


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next